Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jan-Dec:39:3946320251327621.
doi: 10.1177/03946320251327621. Epub 2025 Apr 11.

Causal association between type 1 diabetes and autoimmune cholestasis: A bi-directional Mendelian randomized study

Affiliations

Causal association between type 1 diabetes and autoimmune cholestasis: A bi-directional Mendelian randomized study

Yuanda Liu et al. Int J Immunopathol Pharmacol. 2025 Jan-Dec.

Abstract

Explore the causal relationship of risk between type 1 diabetes and primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC). A causal association between type 1 diabetes and autoimmune liver disease remains ambiguous. This study explored potential causality between different autoimmune conditions, indicating that caution should be taken of the occurrence of autoimmune liver diseases in daily management of T1D patients. Genetic variants were extracted as instrumental variables from the genome-wide association study (GWAS) of PBC, PSC, type 1 diabetes (T1D), and type 2 diabetes (T2D). Associations between four primary liver enzymes, alkaline phosphatase (ALP), aspartate aminotransferase (AST), alanine transferase (ALT), and glutamyl transaminase (GGT), and blood glucose-related indicators such as 2h-glucose post-challenge (2hGlu), fasting glucose (FG), fasting insulin (FI), and glycated hemoglobin (HbA1c) were also evaluated (GWAS p-value < 5 × 10-8). A bi-directional two-sample Mendelian randomization (MR) design was used to assess causality between type 1 diabetes and autoimmune cholestasis. Genetic susceptibility to T1D increased the risk of PSC and PBC. Genetic susceptibility to T2D reduced the risk of PSC and showed no correlation with PBC. Genetically susceptibility to PBC increased the risk of T1D and showed no correlation with T2D. Genetically susceptibility to PSC did not impact the risk of T1D and T2D. T1D patients have an increased risk of PBC/PSC, but such causation is not mediated or explained by the altered blood glucose levels. A bi-directional causal association was identified between type 1 diabetes and autoimmune cholestasis. The findings provide new insight into the management of patients with these conditions.

Keywords: mendelian randomization; primary biliary cholangitis; primary sclerosing cholangitis; type 1 diabetes; type 2 diabetes.

PubMed Disclaimer

Conflict of interest statement

Declaration of conflicting interestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1.
Figure 1.
Study design.
Figure 2.
Figure 2.
Forest plot of Mendelian randomization results using the IVW method. PBC, PSC, ALT, ALP, AST, and GGT are the exposures, and T1D, T2D, 2hGlu, FG, FI, and HbA1c are the outcomes. OR (odds ratio). Note that the confidence interval will not display if it is too narrow. The solid circle represents an association with a p-value < 0.05 and the hollow circle represents a p-value ⩾ 0.05.
Figure 3.
Figure 3.
Forest plot of Mendelian randomization results using the IVW method. T1D, T2D, 2hGlu, FG, FI, and HbA1c are the exposures, and PBC, PSC, ALT, ALP, AST, and GGT are the outcomes. OR (odds ratio). Note that the confidence interval will not display if it is too narrow. The solid circle represents the association with a p-value < 0.05 and the hollow circle represents a p-value ⩾0.05.

References

    1. Targher G, Corey KE, Byrne CD, et al. (2021) The complex link between NAFLD and type 2 diabetes mellitus – mechanisms and treatments. Nature Reviews Gastroenterology & Hepatology 18(9): 599–612. - PubMed
    1. Nawrot M, Peschard S, Lestavel S, et al. (2021) Intestine–liver crosstalk in Type 2 Diabetes and non–alcoholic fatty liver disease. Metabolism 123: 154844. - PubMed
    1. Terziroli Beretta–Piccoli B, Mieli–Vergani G, Vergani D, et al. (2019) The challenges of primary biliary cholangitis: What is new and what needs to be done. Journal of Autoimmunity 105: 102328. - PubMed
    1. Chen L, Zhao Y, Li M, et al. (2024) Proteome–wide Mendelian randomization highlights AIF1 and HLA–DQA2 as targets for primary sclerosing cholangitis. Hepatology International 18(2): 517–28. - PubMed
    1. Jensen AH, Winther–Sørensen M, Burisch J, et al. (2023) Autoimmune liver diseases and diabetes: A propensity score matched analysis and a proportional meta–analysis. Liver International 43(11): 2479–91. - PubMed

MeSH terms

LinkOut - more resources